Investigating the best biopsy methods for Barrett's Esophagus
Official title: The Prevalence, Risk Factors and Optimal Biopsy Protocol of Barrett's Esophagus in Taiwan - A Prospective Randomized Study
Run by E-DA Hospital · NCT05818072 · Data updated 2026-11-12
This study is testing different biopsy methods to see which one works best for finding early signs of Barrett's Esophagus in patients, especially in Asian populations.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years and up |
| Sex | All |
| Enrollment | 165 (estimated) |
| Sponsor | E-DA Hospital Academic / other |
| Locations | 1 site (Kaohsiung City) |
| Status | Recruiting |
| Started | March 13, 2023 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2026 |
| Registry record updated | May 11, 2023 |
| Trial ID | NCT05818072 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults with a columnar-lined esophagus.
✕Probably not a fit
Patients with a history of endoscopic treatment for Barrett's Esophagus or upper gastrointestinal malignancy will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to determine the optimal biopsy protocol for Barrett's Esophagus (BE), a condition that can lead to esophageal adenocarcinoma. It focuses on the prevalence and risk factors associated with BE, particularly in Asian populations, where data is limited. The study will compare different biopsy methods, including one biopsy, three biopsies, and the Seattle protocol, to assess their effectiveness in detecting intestinal metaplasia and dysplasia. By understanding the best practices for biopsy, the study seeks to improve surveillance and management of patients with BE.
Why it matters
Potential benefit: If successful, this study could enhance early detection and management of Barrett's Esophagus, potentially reducing the risk of progression to esophageal cancer.
How similar studies have gone: Other studies have indicated the importance of biopsy protocols in Barrett's Esophagus, but this specific approach in the Asian context is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults with columnar-lined esophagus Exclusion Criteria: * A prior history of endoscopic treatment for Barrett's Esophagus * A prior history of upper gastrointestinal malignancy * A prior history of total or subtotal gastrectomy * Esophageal varices noted during the procedure * Uncontrolled coagulopathy * Taking antiplatelet drug or anticoagulant
Where it's running
-
E-DA Hospital
Kaohsiung City, Taiwan Recruiting
Study contacts
- Study coordinator: Ying-Nan Tsai, M.D
- Email: littlepig9933@gmail.com
- Phone: 886-7-6150011
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Microplastic exposure and progression of stomach precancerous changes
This project will test if adults with higher microplastic exposure are more likely to have precancerous stomach changes or gastric cancer.
-
Endoscopic screening for H. pylori, intestinal metaplasia, and Barrett's mucosa during screening colonoscopy
This project will try adding a gastroscopy with biopsies to routine screening colonoscopy to see how often H. pylori and early stomach changes appear in adults without upper GI symptoms.
-
Using a capsule system to detect Barrett's Esophagus
This study is testing a new capsule system to see if it can help find Barrett's Esophagus in adults who have had an endoscopy recently.
-
Using tissue, brush, and blood tests to improve cancer risk prediction and quality of life tracking in Barrett's Esophagus
This will try extra biopsies, esophageal brushings, blood tests, and short questionnaires to see if they can better predict cancer risk and track quality of life for adults with Barrett's Esophagus who are being evaluated for possible early cancer.
-
Registry and study on Helicobacter Pylori and related gastric conditions
This study is trying to track how Helicobacter pylori infections affect the development of stomach problems, like pre-cancerous changes and cancer, in adults over time.
-
Predicting gastric cancer risk in patients with intestinal metaplasia and atrophic gastritis
This study is trying to find out which factors can help predict the risk of gastric cancer in patients who have intestinal metaplasia and atrophic gastritis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.